Filing Flows

Filing Flows › Xylem (XYL) › Q4 2025

Xylem (XYL) Q4 2025 earnings results (fourth quarter 2025)

10-K filed Feb 25, 2026

Xylem (XYL) reported revenue of $2.4B for the fourth quarter 2025 (Q4 2025), +6% from a year earlier and +6% from the quarter before. Operating margin was 14.7%, net earnings $333M (13.9% of revenue).

Revenue$2.4B
Year over year+6%
Quarter over quarter+6%
Operating margin14.7%
Net earnings$333M

Xylem, Q4 2025: revenue $2.4B (+6% year over year), operating margin 14.7%, net earnings $333M, operating cash flow $543M. The chart follows the revenue to costs, profit and cash.

Q4 2025AmountQ/QY/Y
Revenue$2.4B+6%+6%
Gross profit$932M+6%+9%
Operating profit$353M+6%+32%
Net earnings$333M+47%+2%
Operating cash flow$543M+51%-6%
Free cash flow$460M+64%-3%

What changed

Revenue was $2.4B in Q4 2025, up 6% year over year and up 6% from the previous quarter. Product was the largest line at 83% of revenue.

Gross margin was 38.9%, up 0.9 points from a year earlier. Operating profit was $0.35B, a 14.7% margin (up 2.9 points year over year). Of the extra revenue versus a year earlier, 61% reached operating profit, above the 12% margin then. Operating expenses fell 2% while revenue rose 6%. The fastest-growing cost line was Other operating costs (+32%). Net earnings were $0.34B, up 3% year over year. The effective tax rate was 9.5%.

Operating cash flow was $0.54B (down 6% year over year), 163% of net earnings. Non-cash charges added back $0.14B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items added $0.05B. Capital expenditures of $0.08B left free cash flow of $0.46B.

Questions

What was Xylem's revenue in the fourth quarter 2025?

Xylem (XYL) reported revenue of $2.4B for the fourth quarter 2025 (Q4 2025), +6% from a year earlier and +6% from the quarter before.

Was Xylem profitable in the fourth quarter 2025?

Operating profit was $353M (14.7% of revenue) and net earnings $333M.

Open the interactive Sankey →

Source: Xylem 10-K on SEC EDGAR.